Physician profile
John Petolillo
NPI 1780684084
$1,048.33
in general payments reported to CMS, 2019-2025
10 companies · $47.85 in 2025
The $47.85 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $100 · 2021: $366 · 2023: $74.49 · 2024: $294 · 2025: $47.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $506.08 | 2021-2024 | Persona |
| Stryker Corporation | $172.55 | 2019-2024 | Mako |
| Exactech, INC. | $100.01 | 2020 | |
| Microport Orthopedics INC | $54.87 | 2023 | Mpo Hip System |
| Pacira Therapeutics, INC. | $53.11 | 2019 | |
| Tersera Therapeutics LLC | $41.30 | 2019 | |
| Depuy Synthes Sales INC. | $39.83 | 2019-2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $32.32 | 2025 | |
| Heraeus Medical, LLC. | $25.12 | 2023-2024 | Palacos |
| Ermi LLC | $23.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Petolillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.